OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Parkinson's disease – genetic cause
Ajith Cherian, Divya K.P, Asish Vijayaraghavan
Current Opinion in Neurology (2023) Vol. 36, Iss. 4, pp. 292-301
Closed Access | Times Cited: 33
Ajith Cherian, Divya K.P, Asish Vijayaraghavan
Current Opinion in Neurology (2023) Vol. 36, Iss. 4, pp. 292-301
Closed Access | Times Cited: 33
Showing 1-25 of 33 citing articles:
Mitochondrial Dynamics in Neurodegenerative Diseases: Unraveling the Role of Fusion and Fission Processes
Hubert Grel, Damian Woźnica, Katarzyna Ratajczak, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13033-13033
Open Access | Times Cited: 42
Hubert Grel, Damian Woźnica, Katarzyna Ratajczak, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13033-13033
Open Access | Times Cited: 42
Role of GABA pathway in motor and non-motor symptoms in Parkinson's disease: a bidirectional circuit
Bandar Alharbi, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 16
Bandar Alharbi, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 16
α7‐Nicotinic Acetylcholine Receptor and Mutated α‐Synuclein Interact in Motor Behaviour and Nigrostriatal Dopamine—Findings With Potential Relevance for a Protective Effect of Cigarette Smoking and Parkinson's Disease
Christian Pifl, Alexandra Wolf, Mark Elevado, et al.
European Journal of Neuroscience (2025) Vol. 61, Iss. 6
Open Access | Times Cited: 2
Christian Pifl, Alexandra Wolf, Mark Elevado, et al.
European Journal of Neuroscience (2025) Vol. 61, Iss. 6
Open Access | Times Cited: 2
Defining Parkinson’s Disease: Past and Future
Kristína Kulcsarová, Matěj Škorvánek, Ronald B. Postuma, et al.
Journal of Parkinson s Disease (2024) Vol. 14, Iss. s2, pp. S257-S271
Open Access | Times Cited: 13
Kristína Kulcsarová, Matěj Škorvánek, Ronald B. Postuma, et al.
Journal of Parkinson s Disease (2024) Vol. 14, Iss. s2, pp. S257-S271
Open Access | Times Cited: 13
Nicotinic Acetylcholine Receptors in Glial Cells as Molecular Target for Parkinson’s Disease
Érica Novaes Soares, Ana Carla dos Santos Costa, Gabriel de Jesus Ferrolho, et al.
Cells (2024) Vol. 13, Iss. 6, pp. 474-474
Open Access | Times Cited: 10
Érica Novaes Soares, Ana Carla dos Santos Costa, Gabriel de Jesus Ferrolho, et al.
Cells (2024) Vol. 13, Iss. 6, pp. 474-474
Open Access | Times Cited: 10
Revolutionizing our understanding of Parkinson’s disease: Dr. Heinz Reichmann’s pioneering research and future research direction
Masaru Tanaka, László Vécsei
Journal of Neural Transmission (2024) Vol. 131, Iss. 12, pp. 1367-1387
Open Access | Times Cited: 10
Masaru Tanaka, László Vécsei
Journal of Neural Transmission (2024) Vol. 131, Iss. 12, pp. 1367-1387
Open Access | Times Cited: 10
DNA Damage and Parkinson’s Disease
Gerd P. Pfeifer
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4187-4187
Open Access | Times Cited: 8
Gerd P. Pfeifer
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4187-4187
Open Access | Times Cited: 8
From Brain to Muscle: The Role of Muscle Tissue in Neurodegenerative Disorders
Elisa Duranti, Chiara Villa
Biology (2024) Vol. 13, Iss. 9, pp. 719-719
Open Access | Times Cited: 8
Elisa Duranti, Chiara Villa
Biology (2024) Vol. 13, Iss. 9, pp. 719-719
Open Access | Times Cited: 8
Effects of Transcranial Direct Current Stimulation on Potential P300-Related Events and Alpha and Beta EEG Band Rhythms in Parkinson's Disease
Rosa Angela Fabio, Rossella Suriano, Antonio Gangemi
Journal of Integrative Neuroscience (2024) Vol. 23, Iss. 2, pp. 25-25
Open Access | Times Cited: 7
Rosa Angela Fabio, Rossella Suriano, Antonio Gangemi
Journal of Integrative Neuroscience (2024) Vol. 23, Iss. 2, pp. 25-25
Open Access | Times Cited: 7
Nicotinic Acetylcholine Receptors in Glial Cells as Molecular Target for Parkinson’s Disease
Érica Novaes Soares, Ana Carla dos Santos Costa, Gabriel de Jesus Ferrolho, et al.
(2024)
Open Access | Times Cited: 5
Érica Novaes Soares, Ana Carla dos Santos Costa, Gabriel de Jesus Ferrolho, et al.
(2024)
Open Access | Times Cited: 5
Post-translational modification and mitochondrial function in Parkinson’s disease
Shishi Luo, Danling Wang, Zhuohua Zhang
Frontiers in Molecular Neuroscience (2024) Vol. 16
Open Access | Times Cited: 4
Shishi Luo, Danling Wang, Zhuohua Zhang
Frontiers in Molecular Neuroscience (2024) Vol. 16
Open Access | Times Cited: 4
Next Generation Sequencing Analysis in Patients Affected by Parkinson’s Disease and Correlation Between Genotype and Phenotype in Selected Clinical Cases
Andrea Pilotto, Mattia Carini, Roberto Bresciani, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2397-2397
Open Access
Andrea Pilotto, Mattia Carini, Roberto Bresciani, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2397-2397
Open Access
PADG‐Pred: Exploring Ensemble Approaches for Identifying Parkinson's Disease Associated Biomarkers Using Genomic Sequences Analysis
Ayesha Karim, Tamim Alkhalifah, Fahad Alturise, et al.
IET Systems Biology (2025) Vol. 19, Iss. 1
Open Access
Ayesha Karim, Tamim Alkhalifah, Fahad Alturise, et al.
IET Systems Biology (2025) Vol. 19, Iss. 1
Open Access
Multidimensional mechanisms of anxiety and depression in Parkinson’s Disease: integrating neuroimaging, neurocircuits, and molecular pathways
Jihu Zhao, Huafang Jia, Pengju Ma, et al.
Pharmacological Research (2025), pp. 107717-107717
Open Access
Jihu Zhao, Huafang Jia, Pengju Ma, et al.
Pharmacological Research (2025), pp. 107717-107717
Open Access
Deciphering shared molecular dysregulation across Parkinson’s disease variants using a multi-modal network-based data integration and analysis
Alise Žagare, Irina Balaur, Adrien Rougny, et al.
npj Parkinson s Disease (2025) Vol. 11, Iss. 1
Open Access
Alise Žagare, Irina Balaur, Adrien Rougny, et al.
npj Parkinson s Disease (2025) Vol. 11, Iss. 1
Open Access
Loss of NgBR causes neuronal damage through decreasing KAT7-mediated RFX1 acetylation and FGF1 expression
Yuwei Hu, Yanni Ma, Lele Liu, et al.
Cellular and Molecular Life Sciences (2025) Vol. 82, Iss. 1
Open Access
Yuwei Hu, Yanni Ma, Lele Liu, et al.
Cellular and Molecular Life Sciences (2025) Vol. 82, Iss. 1
Open Access
Computational drug repurposing in Parkinson’s disease: Omaveloxolone and cyproheptadine as promising therapeutic candidates
Xin Guo, Jie Wang, Hongyang Fan, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Xin Guo, Jie Wang, Hongyang Fan, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Genetic study of the NUS1 gene variants in Han Chinese patients with Parkinson’s disease
Cui Gao, Lamei Yuan, Wen Zheng, et al.
Ageing and Neurodegenerative Diseases (2025)
Open Access
Cui Gao, Lamei Yuan, Wen Zheng, et al.
Ageing and Neurodegenerative Diseases (2025)
Open Access
The Effectiveness and Safety Analysis of Duloxetine in Treating Comorbid Depression in Parkinson's Disease: A Retrospective Study
Zhuoqun Wang, Jing Tian, Weixin Dai, et al.
Actas Españolas de Psiquiatría (2024) Vol. 52, Iss. 5, pp. 607-615
Open Access | Times Cited: 2
Zhuoqun Wang, Jing Tian, Weixin Dai, et al.
Actas Españolas de Psiquiatría (2024) Vol. 52, Iss. 5, pp. 607-615
Open Access | Times Cited: 2
Salidroside: An Overview of Its Promising Potential and Diverse Applications
Keke Liang, Shuhe Ma, Kai Luo, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1703-1703
Open Access | Times Cited: 2
Keke Liang, Shuhe Ma, Kai Luo, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1703-1703
Open Access | Times Cited: 2
Leveraging genetic diversity to understand monogenic Parkinson's disease's landscape in AfrAbia.
Wael Mohamed
PubMed (2023) Vol. 12, Iss. 4, pp. 108-122
Closed Access | Times Cited: 4
Wael Mohamed
PubMed (2023) Vol. 12, Iss. 4, pp. 108-122
Closed Access | Times Cited: 4
Ribose-cysteine and levodopa abrogate Parkinsonism via the regulation of neurochemical and redox activities in alpha-synuclein transgenic Drosophila melanogaster models
Olumayowa K. Idowu, A.A. Oremosu, O.O. Dosumu, et al.
Fly (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 1
Olumayowa K. Idowu, A.A. Oremosu, O.O. Dosumu, et al.
Fly (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 1
Exploring Natural Compounds as Potential MAO-B Inhibitors for Parkinson's Disease Treatment: Insights from Docking Simulations and Toxicity Predictions
Ivan Vito Ferrari
(2024)
Open Access | Times Cited: 1
Ivan Vito Ferrari
(2024)
Open Access | Times Cited: 1
Nicotinic Acetylcholine Receptors in Glial Cells as Molecular Target for Parkinson’s Disease
Érica Novaes Soares, Ana Carla dos Santos Costa, Gabriel de Jesus Ferrolho, et al.
(2024)
Open Access | Times Cited: 1
Érica Novaes Soares, Ana Carla dos Santos Costa, Gabriel de Jesus Ferrolho, et al.
(2024)
Open Access | Times Cited: 1
The p.Val234Met LRP10 likely pathogenic variant associated with Parkinson's disease: Possible molecular implications
Andrea Pilotto, Mattia Carini, Alessandro Lupini, et al.
Parkinsonism & Related Disorders (2024) Vol. 123, pp. 106973-106973
Closed Access | Times Cited: 1
Andrea Pilotto, Mattia Carini, Alessandro Lupini, et al.
Parkinsonism & Related Disorders (2024) Vol. 123, pp. 106973-106973
Closed Access | Times Cited: 1
